Kpr Life Sciences And Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.25 Cr
as on 16-11-2024
- Revenue -39.29%
(FY 2023)
- Profit 27.18%
(FY 2023)
- Ebitda 18.04%
(FY 2023)
- Net Worth 40.32%
(FY 2023)
- Total Assets 38.34%
(FY 2023)
About Kpr Life Sciences And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajasekhar Kothuru and Yanadamma Kothuru serve as directors at the Company.
- CIN/LLPIN
U85110AP2011PTC074360
- Company No.
074360
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kpr Life Sciences And Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajasekhar Kothuru  | Director | 09-May-2011 | Current |
| Yanadamma Kothuru | Director | 09-May-2011 | Current |
Financial Performance of Kpr Life Sciences And Research.
Kpr Life Sciences And Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.29% decrease. The company also saw a substantial improvement in profitability, with a 27.18% increase in profit. The company's net worth Soared by an impressive increase of 40.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kpr Life Sciences And Research?
In 2023, Kpr Life Sciences And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Lakshmi Narasimha Spinning Mills (India) Private LimitedActive 19 years 26 daysRajasekhar Kothuru is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Oct 2017 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Kpr Life Sciences And Research?
Unlock and access historical data on people associated with Kpr Life Sciences And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kpr Life Sciences And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kpr Life Sciences And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
